BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Keraplast Technologies Extends Wound Care Distribution Network to Turkey


6/21/2012 9:47:52 AM

San Antonio, June 20, 2012 (GLOBE NEWSWIRE) -- Keraplast Technologies, LLC the developer of ReplicineTM Functional Keratin®Advanced Wound care products announced today having entered an agreement with Gramatek Ltd, for distribution of their advanced wound care products to Hospitals and wound care centers throughout Turkey. Partnering with Gramatek provides Keraplast access to Hospitals, Clinics and strategic Points of service centers throughout key regional areas of Turkey, said Michael Espensen, CEO of Keraplast Technologies, LLC. "We are extremely pleased to enter into this agreement with such an esteemed organization and to provide members served by Gramatek with our paradigm changing line of Replicine™ Functional Keratin® products. Clinicians in many regions of the world, including the USA, Europe, Australia, New Zealand, South Africa, and now Turkey can utilize the latest clinical advancement in wound healing. The global interest in kerasorb®, keramatrix®, keragel™ and keragelT™ is expanding quickly and were putting in a strong network to provide good support wherever the products are in demand".

Read at GlobeNewswire

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES